RIGI and nasopharyngeal carcinoma: To further examine the effector mechanisms involved in RIG‐I regulation of paclitaxel resistance in NPC cells, we performed microarray experiments on paclitaxel‐treated CNE1/shNC and CNE1/shRIG‐I cells.